On June 18 in Beijing, China Council for the Promotion of International Trade
president Ren Hongbin met with Sorensen, chairman of the Novo Nordisk Foundation
and chairman of Novo Nordisk’s board. They discussed Novo Nordisk deepening its
China market presence, accelerating in‑China investment, strengthening biopharma
cooperation with Chinese partners, and increasing participation in the Healthy
China initiative.